NanoPharmaceuticals

About:

A clinical-stage company developing targeted therapeutics for cancer, inflammatory disorders, angio-proliferative diseases

Website: https://www.nanopharmaceuticals.com

Description:

Developing targeted therapeutics for cancer, inflammatory disorders, and angio-proliferative diseases.

Total Funding Amount:

$5.95M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2013-01-01

Contact Email:

jlynch(AT)nanopharmaceuticals.com

Founders:

Paul Davis, Shaker Mousa

Number of Employees:

1-10

Last Funding Date:

2018-08-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai